H&T Presspart is delighted to announce that we will be exhibiting as a Platinum sponsor at this year’s Drug Delivery to the Lungs Conference (DDL) taking place in Edinburgh, from 10-12 December 2025.

You can find H&T Presspart at stand 170 to learn more about how we are leading the industry transition to lower global warming potential (GWP) propellant MDI’s. Alongside our broad MDI componentry range, we can also support our customer’s developments with both HFA152a and HFO1234ze with a wide range of services including GMP standard batch filling for clinical trials.

We will also be showcasing our full range of inhalation drug delivery components, including metered-dose inhalers (MDIs), metered-dose canisters, and our range of dose counters for MDIs.

Also on display will be our Sunriser® high performance DPI technology, which delivers dry powder formulations with fine particle fractions higher than currently marketed devices. This technology is suitable for various formulation types, including classic carrier-based formulations or spray-dried particles alone.

In it’s 36th year the DDL attracts more than 1100 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by 117 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event.  DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.

If you are attending DDL 2025 and would like to arrange a meeting, please contact the team.

We look forward to seeing you in Edinburgh!